1. Home
  2. NMRA vs KOPN Comparison

NMRA vs KOPN Comparison

Compare NMRA & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • KOPN
  • Stock Information
  • Founded
  • NMRA 2019
  • KOPN 1984
  • Country
  • NMRA United States
  • KOPN United States
  • Employees
  • NMRA N/A
  • KOPN N/A
  • Industry
  • NMRA
  • KOPN Semiconductors
  • Sector
  • NMRA
  • KOPN Technology
  • Exchange
  • NMRA Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • NMRA 287.6M
  • KOPN 282.1M
  • IPO Year
  • NMRA 2023
  • KOPN 1992
  • Fundamental
  • Price
  • NMRA $1.13
  • KOPN $1.38
  • Analyst Decision
  • NMRA Buy
  • KOPN Strong Buy
  • Analyst Count
  • NMRA 8
  • KOPN 4
  • Target Price
  • NMRA $10.14
  • KOPN $2.63
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • KOPN 2.3M
  • Earning Date
  • NMRA 03-03-2025
  • KOPN 05-13-2025
  • Dividend Yield
  • NMRA N/A
  • KOPN N/A
  • EPS Growth
  • NMRA N/A
  • KOPN N/A
  • EPS
  • NMRA N/A
  • KOPN N/A
  • Revenue
  • NMRA N/A
  • KOPN $44,266,305.00
  • Revenue This Year
  • NMRA N/A
  • KOPN $21.20
  • Revenue Next Year
  • NMRA N/A
  • KOPN $13.55
  • P/E Ratio
  • NMRA N/A
  • KOPN N/A
  • Revenue Growth
  • NMRA N/A
  • KOPN 0.60
  • 52 Week Low
  • NMRA $1.13
  • KOPN $0.56
  • 52 Week High
  • NMRA $17.19
  • KOPN $2.17
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.07
  • KOPN 47.23
  • Support Level
  • NMRA $1.13
  • KOPN $1.32
  • Resistance Level
  • NMRA $1.23
  • KOPN $1.48
  • Average True Range (ATR)
  • NMRA 0.12
  • KOPN 0.12
  • MACD
  • NMRA 0.05
  • KOPN 0.01
  • Stochastic Oscillator
  • NMRA 3.54
  • KOPN 64.71

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: